IRIS
LIBETTA, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.215
AS - Asia 4.614
EU - Europa 3.660
SA - Sud America 737
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 98
OC - Oceania 8
Totale 15.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.101
CN - Cina 2.258
SG - Singapore 1.070
IE - Irlanda 889
BR - Brasile 581
UA - Ucraina 577
HK - Hong Kong 504
FI - Finlandia 375
DE - Germania 374
VN - Vietnam 364
RU - Federazione Russa 308
SE - Svezia 281
IT - Italia 278
FR - Francia 233
GB - Regno Unito 179
IN - India 102
AR - Argentina 59
BD - Bangladesh 52
CA - Canada 51
BE - Belgio 43
MX - Messico 41
IQ - Iraq 39
EC - Ecuador 34
ZA - Sudafrica 31
TR - Turchia 30
JP - Giappone 28
NL - Olanda 24
CZ - Repubblica Ceca 21
ID - Indonesia 21
MA - Marocco 20
PL - Polonia 19
PK - Pakistan 18
VE - Venezuela 17
CO - Colombia 16
PH - Filippine 15
CL - Cile 14
SA - Arabia Saudita 14
JO - Giordania 12
UZ - Uzbekistan 12
LT - Lituania 11
AE - Emirati Arabi Uniti 9
ES - Italia 9
PY - Paraguay 9
AT - Austria 8
KE - Kenya 8
MY - Malesia 8
EG - Egitto 7
MU - Mauritius 7
TN - Tunisia 6
AU - Australia 5
AZ - Azerbaigian 5
KR - Corea 5
NP - Nepal 5
AL - Albania 4
BG - Bulgaria 4
BH - Bahrain 4
CI - Costa d'Avorio 4
ET - Etiopia 4
EU - Europa 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
TT - Trinidad e Tobago 4
OM - Oman 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IR - Iran 2
KG - Kirghizistan 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
TW - Taiwan 2
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 15.320
Salva come PNG Salva come JPEG
Città #
Dublin 887
Chandler 872
Jacksonville 703
San Jose 575
Nanjing 530
Singapore 523
Ashburn 519
Hong Kong 500
Dallas 377
Beijing 331
Boardman 254
Council Bluffs 225
Nanchang 181
Princeton 170
Lawrence 166
Lauterbourg 161
Medford 161
Changsha 158
Shenyang 153
Hebei 151
Wilmington 151
Los Angeles 141
Ho Chi Minh City 119
Jiaxing 112
Hanoi 96
New York 88
Buffalo 79
Tianjin 79
Hangzhou 78
Helsinki 73
Redondo Beach 64
Ann Arbor 59
Santa Clara 57
Munich 56
Woodbridge 56
Milan 46
Moscow 44
São Paulo 44
Brussels 42
Verona 40
Orem 32
Norwalk 31
Shanghai 30
Chicago 29
Pavia 28
Chennai 26
Turku 26
Tokyo 25
Torino 25
Brooklyn 22
Curitiba 20
Montreal 20
Seattle 20
Da Nang 19
Johannesburg 19
Rio de Janeiro 19
Collegno 17
Guangzhou 17
Haiphong 17
Warsaw 17
London 16
Quito 16
The Dalles 16
Brno 14
Frankfurt am Main 14
Houston 14
Phoenix 14
Brasília 13
Fairfield 13
Zhengzhou 13
Columbus 12
Denver 12
Mexico City 12
San Francisco 12
Toronto 12
Amman 11
Amsterdam 11
Baghdad 11
Tashkent 11
Ankara 10
Kunming 10
New Delhi 10
Nuremberg 10
Poplar 10
Falkenstein 9
Jinan 9
Shijiazhuang 9
Stockholm 9
Atlanta 8
Auburn Hills 8
Bogotá 8
Boston 8
Charlotte 8
Guarulhos 8
Porto Alegre 8
Belo Horizonte 7
Caracas 7
Des Moines 7
Dhaka 7
Juiz de Fora 7
Totale 10.004
Salva come PNG Salva come JPEG
Nome #
Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. 169
Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis Treated With Autologous Mesenchymal Stromal Cells: Evaluation of the Contribution of Immune-Mediated Mechanisms. 157
Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. 145
Costimulatory Pathways in Kidney Transplantation: Pathogenetic Role, Clinical Significance and New Therapeutic Opportunities. 143
Regulatory T cells in kidney transplant recipients. 140
Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients 139
ANTIBODY CASES 137
Circulating serum lectins of patients with IgA Nephropathy stimulate IL-6 release from mesangial cells. 136
Multiple electrolyte disorders in a neurosurgical patient: solving the rebus. 130
Hemodialysis stimulates the injurins-hepatocyte growth factor release 130
C-reactive protein and coronary heart disease in hemodialyzed patients. 129
Autoimmune response to heat shock protein 60 in haemodialysis patients 129
Acute effects of cyclosporin on renal hemodinamics and urinary protein excretion in patients with the nephrotic syndrome 122
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane 122
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane. 120
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines 120
Extracellular Vesicles Derived from Mesenchymal Stromal Cells Delivered during Hypothermic Oxygenated Machine Perfusion Repair Ischemic/Reperfusion Damage of Kidneys from Extended Criteria Donors 120
Macrophage stimulating protein (MSP) determina proliferazione e migrazione delle cellule mesangiali 119
) Homocysteine plasma levels correlate with intimal carotid artery tickness in haemodialysis patients. 119
Acute kidney injury: effect of hemodialysis membrane on Hgf and recovery of renal function. 118
Acute Renal and Immunological Effects of Low-dose Cyclosporine In Humans 116
Acute effects of low-dose cyclosporine on renal function and interleukin-2 in humans. 116
Activity of Th1/Th2 lymphocytes in primary and HCV-related mesangiocapillary glomerulonephritis. 116
Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR. 115
· Association between elevated homocysteine levels and interleukin-18 in long-term hemodialysed patients 114
CD73-Adenosinergic Axis Mediates the Protective Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Ischemic Renal Damage in a Rat Model of Donation after Circulatory Death 113
Hemodialysis alters tyrosine phosphorylation in band 3 protein of erythrocytes 113
An open prospective randomized trial to reduce the pain of blood glucose testing: ear versus thumb 113
Acute Effects of Low-dose Cyclosporine On Renal-function In Normal Subjects 112
Acute Effects of Ciclosporin On Renal Hemodynamics and Urinary Protein Excretion In Patients With the Nephrotic Syndrome 112
High-levels of Serum Amyloid-a (saa) and Increased Peripheral-blood Mononuclear-cells (pbmc) Production of Interleukin-6 (il-6) and Beta-2-microglobulin (b-2-m) In Hemodialysis (hd) and Peritoneal-dialysis (capd) Patients 111
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo 110
Prevalence of hyperhomocysteinemia in male hemodialysis patients. 110
Urinary monocyte chemotactic peptide (U/MCP-1) and RANTES (U/RANTES) excretion in human lupus nephritis (SLE/N) 107
Hepatocyte growth factor protects liver against HCV in patients on regular hemodialysis. 107
Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients 107
Acute effects of low dose cyclosporine on renal function in normal subjects. 107
Hepatic growth factor release during b interferon treatment of patients with HCV chronic hepatitis genotipe 1b. 106
Early versus late initiation of dialysis 106
Biocompatibilita' del trattamento emodialitico: confronto tra dialisi extracorporea e dialisi peritoneale. 104
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 103
Oxidative stress and inflammation: Implications in uremia and hemodialysis 102
Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells 102
RBP4: a culprit for insulin resistance in end stage renal disease that can be cleared by hemodiafiltration 102
Role of interleukin18 (IL-18) and interleukin 12 (IL-12) in human lupus nephritis (SLE-N) 101
Homocysteine lowering therapy and erythropoietin resistance in maintenance dialysis patients 101
Hyperhomocysteinemia in renal transplant recipients is influenced by the immunosuppressive regimen 101
Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injury 100
Urinary interleukin-18 (IL-18) and monocyte chemotactic peptide-1 (MCP-1) excretion in IGA Nephropathy (IgAN) 99
Polarization of T-Helper lymphocytes toward Th2 phenotype in uremic patients 99
Atrasentan in patients with diabetes and chronic kidney disease 98
A RARE CASE OF AKI SUSTAINED BY SEGMENTAL ARTERIAL MEDIOLYSIS WITH BILATERAL RENAL INFARCTION 98
Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients 97
[Heparin-induced trombocytopenia: pathogenesis, clinical manifestations and management in hemodialysis] 97
B-type natriuretic peptide dialysis clearance and renal function in patients with decompensated heart failure. 96
Interleukin-6 Production Induced In Peripheral-blood Mononuclear-cells By A Serum Factor From Iga Nephropathy Patients Is Inhibited In-vitro By Specific Sugars 96
Standard Hemodiafiltration Improves diuretic responsiveness in advanced congestive heart failure 95
Severe symptomatic hyponatremia during sibutramine therapy: a case report. 95
Hepatocyte growth factor protects the liver against hepatitis C virus in patients on regular hemodialysis 95
Incidence of SAR and CAN in renal transplant patients treated with different immunosuppressive regimens 95
Serum levels of interleukin12, interleukin 18 and interferon gamma in ischemic acute renal failure (ARF) 95
Standard hemodiafiltration improves diuretic responsiveness in advanced congestive heart failure 93
In-vivo Effects of Intravenous 1,25-dihydroxyvitamin-d3 (1,25-vit-d3) On Interleukin-2 (il-2) Production In Hemodialysis (hd) Patients 93
Produzione dei recettori dell'Interleuchina 2 dalle cellule linfocitarie dei pazienti uremici cronici. 92
Nifedipine But Not Captopril Minimizes the Negative Renal Effects of the High Osmolality Contrast-media In Patients With Reduced Renal-function 92
Hemodialysis Related Induction of Interleukin-6 Production By Peripheral-blood Mononuclear-cells 92
Plasma levels and blood mononuclear cell release of IL-18 in patients on hemodialysis 92
Effects of two-month treatment with low-oral doses of cyclosporin on renal function. 92
Interferong and Interleukin5 production by T helper cells in renal transplant recipients treated with sirolimus-based immunosuppression 91
Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation. 91
Bicarbonate and Calcium Kinetics In Postdilutional Hemodiafiltration 91
Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. 91
Dopamine Counteracts the Acute Renal Effects of Cyclosporine In Normal Subjects 90
Inosine monophosphate dehydrogenase activity after mycophenolate mofetil in renal transplant patients receiving different immunosupressive combined therapy and stable after at least three months' administration. 90
Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factor 90
Determination of tocopherols and their metabolites by liquid-chromatography coupled with tandem mass spectrometry in human plasma and serum 90
Cytokines are "injurin" and cause hepatocyte growth factor release during dialysis. 89
Stimulation of Hepatocyte Growth Factor in human acute renal failure 89
Changes is Th1/Th2 balance in hemodialysis patients: effect of different membranes 89
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus 89
Loop diuretics and renal vasodilators in acute renal failure. 87
B-type natriuretic peptide dialysis clearance and renal function in patients with decompensated heart failure 86
Effetti delle differenti soluzioni di reinfusione sulla cinetica del calcio in corso di Paired Filtration Dialysis 86
Renal Functional Reserve In Renal-transplant Patients On Cyclosporine Therapy 86
Arterial “inflammaging” drives vascular calcification in children on dialysis 86
Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients 86
Plasma fibrinogen and dialysis 85
Produzione linfomonocitaria di interleuchina 12 in pazienti uremici cronici. 85
Inverse association between homocysteine and vascular endothelial growth factor receptor 2 serum levels in hemodialyzed and kidney transplanted patients 85
Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation 85
Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients. 85
Effetti della ciclosporina su colture di fibroblasti e cellule epiteliali tubulari renali. 84
Effects of A 2-month Treatment With Low Oral Doses of Cyclosporine On Renal-function 83
Circulating Levels and Dietary Intake of the Advanced Glycation End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on Conservative Predialysis Therapy: A Pilot Study 83
Renal Hemodynamic-effects of Short-term Therapy With Low-doses of Cyclosporine A In Humans With Intact Kidneys 83
Mycophenolate mofetil in primary glomerulopathies 83
L'emodialisi induce una variazione conformazionale della beta-2 microglobulina (B-2M) espressa sulla superficie dei leucociti circolanti 83
Bicarbonate and calcium kinetics in postdilutional hemodiafiltration 83
Standard hemodiafiltration improves diuretic responsiveness in advanced congestive heart failure. 82
Renal Functional Reserve - Its Significance In Normal and Salt Depletion Conditions 82
Totale 10.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022701 0 3 6 9 48 20 12 30 41 17 117 398
2022/20232.471 265 151 37 234 240 265 1 138 1.052 11 52 25
2023/2024661 113 106 16 82 74 185 13 35 6 11 13 7
2024/20252.094 39 190 67 75 67 50 132 166 427 81 214 586
2025/20264.992 368 415 630 550 544 261 970 121 396 403 192 142
2026/2027313 129 184 0 0 0 0 0 0 0 0 0 0
Totale 15.513